Sunday, March 1, 2009

Generic Prilosec Hits the Market

The Food and Drug Administration has approved Impax Laboratories Inc.’s Abbreviated New Drug Application for a generic version of Prilosec.

Prilosec is marketed by AstraZeneca for the treatment of duodenal/gastric ulcers and gastro-esophageal reflux disease (GERD).

The new approval is for 40-mg delayed-release capsules.

Prilosec is not without serious side effects.

No comments: